Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.4600 (2.61%) ($8.4600 - $8.4900) on Fri. Dec. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.34% (three month average) | RSI | 83 | Latest Price | $8.4600(2.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 23.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.67% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.67% (StdDev 5.34%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $8.37(1.08%) | 10 Day Moving Average | $8(5.75%) | 20 Day Moving Average | $6.56(28.96%) | To recent high | -0.8% | To recent low | 68% | Market Cap | $1.493b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |